Per Karlsson - Concepedia

Author

Per Karlsson

Also Known As

A Ringberg, A von Wachenfeldt, Andrea Varrone, Antoniou, Antonis C., B. Arver, Caligo, Maria A., Ejlertsen, B., Grazia Lombardi, Hans Ehrencrona, Karlsson Per

549

Publications

20.3K

Citations

H-Index

232

Concepts

All Affiliations

Sahlgrenska University Hospital Karolinska Institutet University of Gothenburg Karolinska University Hospital Lund University

About

Per Karlsson is an author at Sahlgrenska University Hospital specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	85	8.7K
2	Health Sciences	13	14	4.3K
3	Engineering	12	16	817
4	Business	1	1	28
5	Law	1	1	26

Per Karlsson

187

Publications

19.1K

Citations

H-Index

Page 1

	Year	Citations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Annals of Oncology Surgical OncologyBreast OncologyCancer ManagementPrimary TherapyPathology	2013	3.6K
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan S. Coates, Eric P. Winer, Aron Goldhirsch, Annals of Oncology	2015	1.8K
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer, Annals of Oncology	2017	1.2K
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V Marco Colleoni, Zhuoxin Sun, Karen N. Price, Journal of Clinical Oncology	2016	600
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial Viviana Galimberti, Bernard F. Cole, Giuseppe Viale, The Lancet Oncology Surgical OncologyBreast OncologyMedicineIbcsg 23-01Breast Cancer	2018	533
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos, The Lancet Oncology Breast OncologyOncologyPharmacologyImmune Checkpoint InhibitorBreast Cancer	2019	464
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome Emman Shubbar, Anikó Kovács, Shahin Hajizadeh, BMC Cancer	2013	399
DC bus voltage control for a distributed power system Per Karlsson, J. Svensson IEEE Transactions on Power Electronics Electrical EngineeringEngineeringDc MicrogridsSmart GridDc Power Systems	2003	363
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients Anna Nordström, Lars Farde, Sigrid Nyberg, American Journal of Psychiatry	1995	337
Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study Michael Andersson, Elisabeth Lidbrink, Karsten Bjerre, Journal of Clinical Oncology	2010	291

Page 1